Documentos relacionados

1. Role of Ca²⁺ in healthy and pathologic cardiac function: from normal excitation-contraction coupling to mutations that cause inherited arrhythmia.
2. Pharmacological Management of Cardiac Arrhythmias in the Fetal and Neonatal Periods: A Scientific Statement From the American Heart Association: Endorsed by the Pediatric & Congenital Electrophysiology Society (PACES).
3. RyR2 inhibition with dantrolene is antiarrhythmic, prevents further pathological remodeling, and improves cardiac function in chronic ischemic heart disease.
4. Fosphenytoin for control of electrical storm in acute myocardial infarction and Purkinje fiber-mediated arrhythmias.
5. Pharmacotherapy in Ventricular Arrhythmias.
6. Etiologies, Mechanisms, Management, and Outcomes of Electrical Storm.
7. Contemporary updates on ventricular arrhythmias: from mechanisms to management.
8. Molecular Pathways and Animal Models of Arrhythmias.
9. Novel cases of pediatric sudden cardiac death secondary to TRDN mutations presenting as long QT syndrome at rest and catecholaminergic polymorphic ventricular tachycardia during exercise: The TRDN arrhythmia syndrome.
10. Intramural mapping of intramural septal ventricular arrhythmias.